Your session is about to expire
← Back to Search
Riluzole for Atrial Fibrillation (SOLUTION Trial)
SOLUTION Trial Summary
This trial will study whether or not riluzole, a drug used to manage amyotrophic lateral sclerosis (ALS), can effectively suppress triggered atrial arrhythmias in people with atrial fibrillation (AF).
SOLUTION Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSOLUTION Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.SOLUTION Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a serious heart valve condition.I am not taking medications like cimetidine or ciprofloxacin.I am taking or will take blood thinners for a heart rhythm correction procedure.I had Wolff-Parkinson-White syndrome but it was successfully treated.My atrial fibrillation is caused by a temporary condition like an electrolyte imbalance.I am over 18 and have had AF symptoms confirmed by an ECG in the last year.I have a heart condition where the tissue becomes thick or stiff.I am a woman who cannot become pregnant or am following strict birth control methods.I have severe heart failure but haven't had worsening symptoms in the last month.I haven't had a heart attack, heart surgery, or angioplasty in the last month.I am not on any medication for irregular heartbeats as per my doctor's advice.You are currently smoking or using tobacco products.I have had fainting spells or chest pain caused by an irregular heartbeat.I have had a type of fast heart rate or a cardiac arrest.I have a type of irregular heartbeat called polymorphic ventricular tachycardia.I have a history of torsade de pointes.I am scheduled for a procedure to correct my heart rhythm.I am not taking Class I or III antiarrhythmic drugs.
- Group 1: Control
- Group 2: Active
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants have enrolled in this research endeavor?
"Affirmative. Clinicaltrials.gov data reveals that this clinical trial, which began recruiting participants on June 15th 2022 is still open for enrollment and has recently been updated on November 14th 2022. This medical study is seeking 78 volunteers from a single site."
To what extent could Active be detrimental to people?
"Active's safety rating is 2, as the current available data demonstrates its security but not necessarily efficacy."
Is recruitment still underway for this research trial?
"Clinicaltrials.gov reveals that this trial is actively seeking participants, with the initial post dating back to June 15th 2022 and most recent updates occurring on November 14th of the same year."
Share this study with friends
Copy Link
Messenger